Archivio

Choice of first-line ART regimen in PENPACT 1: a randomized trial of combination antiretroviral regimens and treatment switching strategies in antiretroviral naive children >30 days and <18 years of age.

Three year outcomes in children treated with HAART before 3 months of age in the PENTA 7 trial.